A61K 38/095
Oxytocins
Official title: Oxytocins; Vasopressins; Related peptides
A61K38/095 (Oxytocins) appears on 347 US grants and 670 published applications in this corpus.
Search patents in A61K- Granted patents
- 347
- Published applications
- 670
- Assignees
- 309
- Inventors
- 944
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 5 | 0 |
| 1997 | 1 | 0 |
| 1998 | 8 | 0 |
| 1999 | 11 | 0 |
| 2000 | 1 | 0 |
| 2001 | 5 | 3 |
| 2002 | 3 | 6 |
| 2003 | 2 | 5 |
| 2004 | 2 | 15 |
| 2005 | 2 | 9 |
| 2006 | 3 | 18 |
| 2007 | 4 | 17 |
| 2008 | 2 | 18 |
| 2009 | 6 | 20 |
| 2010 | 5 | 30 |
| 2011 | 6 | 22 |
| 2012 | 17 | 28 |
| 2013 | 8 | 28 |
| 2014 | 14 | 30 |
| 2015 | 20 | 38 |
| 2016 | 17 | 37 |
| 2017 | 27 | 53 |
| 2018 | 34 | 56 |
| 2019 | 22 | 28 |
| 2020 | 21 | 38 |
| 2021 | 20 | 31 |
| 2022 | 18 | 34 |
| 2023 | 15 | 28 |
| 2024 | 13 | 33 |
| 2025 | 9 | 24 |
| 2026 | 9 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of treating Prader Willi Syndrome and conditions associated with low basal metabolic rate or hyperphagia using a KATP channel opener29 Sep 2026US 12,746,244 B2Sedogen LLC
- Methods of treating disease with Terlipressin21 Jul 2026US 12,685,756 B2BIOVIE, Inc.
- Cardioprotective lipid and method of use5 May 2026US 12,617,809 B2Signpath Pharma, Inc.
- Pharmaceutical formulations comprising tadalafil14 Apr 2026US 12,599,554 B2KYDES Pharmaceuticals LLC
- Unit dosage form for transmucosal drug delivery of an active pharmaceutical ingredient31 Mar 2026US 12,589,095 B2Primo Pharmatech LLC
- Methods of treating disease with terlipressin8 Oct 2026US 2026/0306580 A1BIOVIE, Inc.
- Intranasal desmopressin administration8 Oct 2026US 2026/0306764 A1Acerus Pharmaceuticals USA, LLC
- Peptide pharmaceuticals for insulin resistance17 Sep 2026US 2026/0273069 A1Mederis Diabetes LLC
- Compositions for treating a subject from sexual dysfunction27 Aug 2026US 2026/0248810 A1
- Compositions for treating an individual for improvement of cognitive functions27 Aug 2026US 2026/0248811 A1
Most cited
By later US patents
- Pulmonary drug delivery system160US 5,451,569 AHong Kong University of Science and Technology R & D Corporation Limited · 1995
- Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device156US 8,764,733 B2Rani Therapeutics, LLC · 2014
- Submicron emulsions for delivery of peptides153US 5,514,670 APharmos Corporation · 1996
- Urologic irrigation solution and method for inhibition of pain, inflammation and spasm152US 5,858,017 AOmeros Medical Systems, Inc. · 1999
- Transparent liquid for encapsulated drug delivery144US 5,707,648 ALDS Technologies, Inc. · 1998